Advertisement
Screener

BONE BIOLOGICS CORPORATION (BBLG) Payments of Stock Issuance Costs

0.9 / 5 stars · 5/28 Roast Me

BONE BIOLOGICS CORPORATION Payments of Stock Issuance Costs

BONE BIOLOGICS CORPORATION (BBLG) reported Payments of Stock Issuance Costs of $647.21 thousand for the 3-month period ending 2025-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Cash Flow › Financing Activities

us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-08-14

  • BONE BIOLOGICS CORPORATION payments of stock issuance costs for the quarter ending 2025-06-30 was $647.21K.
  • BONE BIOLOGICS CORPORATION payments of stock issuance costs for fiscal 2022 was $686.82K, a 36.01% decline from fiscal 2021.
  • BONE BIOLOGICS CORPORATION payments of stock issuance costs for fiscal 2021 was $1.07M.
Period endPayments of Stock Issuance Costs 3 monthPayments of Stock Issuance Costs 12 month
2025-06-30$647.21K
10-Q · filed 2026-08-14
2022-12-31$686.82K
10-K · filed 2023-03-30
2021-12-31$1.07M
10-K · filed 2023-03-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
LogicMark, Inc. (LGMK)United States$0.000B
ENvue Medical, Inc. (FEED)United States$0.011B
Lifeward Ltd. (LFWD)$0.021B
MILESTONE SCIENTIFIC INC. (MLSS)United States$0.036B-6.85
ALPHA PRO TECH LTD (APT)$0.052B13.63
Envoy Medical, Inc. (COCH)United States$0.056B
MYOMO, INC. (MYO)United States$0.065B-2.85
Safe Pro Group Inc. (SPAI)United States$0.090B
LAKELAND INDUSTRIES INC (LAKE)United States$0.104B-4.21
NutriBand Inc. (NTRB)United States$0.109B